LifeWatch AG

EANS-Adhoc: LifeWatch AG
Nominates National Councillor Jürg Stahl, member of the Swiss Parliament, as Candidate for the Board of Directors

@@start.t1@@--------------------------------------------------------------------------------   ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide   distribution. The issuer is solely responsible for the content of this   announcement. --------------------------------------------------------------------------------@@end@@

Company Information

15.04.2010

Neuhausen am Rheinfall / Switzerland, April 15, 2010 - LifeWatch AG   (SIX  Swiss Exchange: LIFE),  the  leading  wireless  remote  cardiac and  medical  patient monitoring service provider in the U.S., announces the  nomination  of  National Councillor Jürg Stahl (Canton of Zurich / SVP) for  election  to  the  Board  of Directors of LifeWatch AG. Ruedi Stoeckly, who has been Member of the  Board  of Directors for many years, will not be available for re-election at the  upcoming Annual Shareholder Meeting.

The Board of Directors of LifeWatch AG proposes to the next  Annual   Shareholder Meeting on May 26th, 2010, to elect National Councillor Jürg Stahl  (SVP)  as  a new member of the Board of Directors for a   term  of  office  of  one  year.  As National Councillor of the Canton of Zurich, Mr. Jürg Stahl is a member  of  the House of Representatives of Switzerland, where  he  is  highly  regarded  as   an experienced healthcare expert. His work in various Federal Commissions  includes his membership of the Federal Commission for Social Security and  Healthcare  of the Swiss National Council (SGK-NR) since 1999. His professional  background  as a member of Executive Board of the health insurance company  Group  Mutuel  will be an additional asset for the Board of Directors of LifeWatch AG.

After the success of its monitoring services in the U.S., LifeWatch now  intends to  expand  its  services  into  attractive  healthcare markets    in    Europe. Consequently the company is seeking to complement its Board with an  experienced politician in the field of healthcare  who  can  serve  the  company  with  his valuable network in Switzerland and beyond,  including  contacts  at  companies, authorities, and service providers in the healthcare industry.

National Councillor Jürg Stahl will succeed Ruedi Stoeckly who has served  as  a Member of the Board since 2003 and who will not be   available  for  re-election. The Board of Directors would  like  to   thank  Mr.  Stoeckly  for  his  valuable contributions during the past years and wishes him  all  the  best.  Apart  from Chairman Yacov Geva, who has a mandate until 2011, all other  Members   including Vice Chairman Urs Wettstein, Gregory Henry Volkart and Dr. Abraham  Sartani  are due for re-election at the Annual General Meeting for a term of  office  of  one year.

About LifeWatch AG LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed  on  SIX  Swiss Exchange (LIFE), Switzerland, is the leading healthcare technology and  solution company,   specializing  in  advanced  telehealth  systems  and  wireless   remote patient monitoring services. LifeWatch services cater  to   individuals,  ranging from high-risk  and  chronically  ill   patients,  to  consumers  of  health  and wellness  products.   LifeWatch  has  subsidiaries  in  the  United  States,  the Netherlands, Japan, the United Kingdom, Switzerland and Israel. LifeWatch AG  is the parent company of  LifeWatch  Services  Inc.,  a leading  US-based  cardiac monitoring  service  provider,  and   manufacturer  of  telecardiology  products.

@@start.t2@@LifeWatch  is  also  introducing  a  new  program  for  Home    SleepTesting    of
Obstructive Sleep Apnea (OSA) patients  under  the  brand  name  NiteWatch.  For
additional        information,        please        visit         www.lifewatch.com       ; ; and
www.nitewatchservices.com@@end@@

Sign-up for customized e-mail alerts and documentation requests is available  at http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking  statements.  All   statements  other than statements of historical facts contained in this press  release,  including statements regarding  future  results of  operations  and  financial  position, business strategy and plans and objectives for future operations,  are  forward- looking statements. The words "believe," "may," "will," "estimate,"   "continue," "anticipate,"  "intend,"  "expect"  and  similar   expressions  are  intended  to identify forward-looking  statements. LifeWatch  AG  has  based  these  forward looking statements largely on current expectations and projections about  future events  and   financial  trends  that  it  believes  may  affect  the    financial condition, results of operations, business strategy, short term  and long  term business operations and objectives, and financial needs.   These  forward-looking statements are subject to a number of risks, uncertainties and  assumptions.  In light of these risks, uncertainties and assumptions, the forward-looking  events and circumstances described may  not  occur  and  actual  results  could differ materially and adversely from those  anticipated  or  implied in  the  forward- looking statements. All  forward-looking   statements  are  based  only  on  data available to LifeWatch AG at the time  of  the  issue  of  this  press  release. LifeWatch AG does not undertake any obligation  to  update  any  forward-looking statements contained in this press release  as  a  result  of  new   information, future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN  THE  UNITED  STATES  OF   AMERICA  AND SHOULD NOT BE DISTRIBUTED TO  UNITED  STATES  PERSONS   OR  PUBLICATIONS  WITH  A GENERAL  CIRCULATION  IN  THE  UNITED   STATES.  THIS  PRESS  RELEASE  DOES    NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR  ANY  OF  ITS  SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE  ANY SECURITIES OF LIFEWATCH  AG  OR  ITS  SUBSIDIARIES  IN  THE  UNITED   STATES.  IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND  ITS   SUBSIDIARIES  HAVE  NOT  BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED,  SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO  U.S.  PERSONS  ABSENT  REGISTRATION UNDER OR AN APPLICABLE EXEMPTION  FROM  THE  REGISTRATION  REQUIREMENTS  OF  THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE  MADE  IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT  MAY  BE  OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN  DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL  STATEMENTS OF THE ISSUER.

@@start.t3@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: LifeWatch AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
For further information on LifeWatch please contact:
Kobi Ben Efraim, Chief Financial Officer, LifeWatch AG
Tel +41 52 632 00 50 | Fax +41 52 632 00 51 | E-mail kobibe@lifewatch.com

Sensus Investor & Public Relations GmbH, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | E-mail lifewatch@sensus.ch

Branche: Healthcare Providers
ISIN:      CH0012815459
WKN:        1281545
Index:    SPI, SPIEX
Börsen:  Frankfurt / Open Market / XETRA
              SIX Swiss Exchange / Hauptsegment
              Berlin / free trade



Weitere Meldungen: LifeWatch AG

Das könnte Sie auch interessieren: